2018 AANS Annual Scientific Meeting-601. Outcomes and management of intracranial hemorrhage (ICH) in patients with ventricular assist devices (VAD)

601. Outcomes and management of intracranial hemorrhage (ICH) in patients with ventricular assist devices (VAD)

Video Transcription

Video Summary

Dr. Grace Yi-Yen Lai presents a study on the outcomes and management of intracranial hemorrhage (ICH) in patients with ventricular assist devices (VADs). VADs are used to support patients with heart failure who are not transplant candidates. One of the major complications of VADs is stroke, with ICH being the leading cause of death after six months. The management of anticoagulation in these patients is challenging due to the risk of pump thrombosis and hematoma expansion. The study analyzes patient characteristics, outcomes, and quality of life based on different types of hemorrhages. The findings suggest guidelines for managing ICH in VAD patients, including the importance of reversing anticoagulation in patients with ICH and considering surgery for subdural hemorrhages. The risk of pump thrombosis after reversal appears to be low.

Asset Caption

Grace Yee Yan Lai, MD

Keywords

Dr. Grace Yi-Yen Lai

intracranial hemorrhage

ventricular assist devices

management

outcomes